Compass Therapeutics, Inc.

CMPX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 25, 2026
8-K Sep 22, 2026 FORM 8-K
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G Aug 7, 2026
10-Q Aug 6, 2026 FORM 10-Q
8-K Aug 6, 2026 FORM 8-K
8-K Jul 1, 2026 FORM 8-K
8-K Jun 23, 2026 FORM 8-K
8-K Jun 11, 2026 FORM 8-K
SCHEDULE 13G/A May 15, 2026
10-Q May 5, 2026 FORM 10-Q
8-K May 5, 2026 FORM 8-K
4/A Apr 30, 2026
4/A Apr 30, 2026
4 Apr 29, 2026
4 Apr 29, 2026
ARS Apr 29, 2026 ARS
DEFA14A Apr 29, 2026 DEFA14A
DEF 14A Apr 29, 2026 DEF 14A
8-K Apr 27, 2026 FORM 8-K
S-8 Mar 12, 2026 S-8
10-K Mar 5, 2026 FORM 10-K
8-K Mar 5, 2026 FORM 8-K
SCHEDULE 13G/A Feb 13, 2026
4 Feb 10, 2026
← Newer Page 1 of 15 · 358 filings Older →